These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35398708)

  • 1. Gene therapy: challenges in cell culture scale-up.
    Shupe J; Zhang A; Odenwelder DC; Dobrowsky T
    Curr Opin Biotechnol; 2022 Jun; 75():102721. PubMed ID: 35398708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in upstream process development for production of recombinant adeno-associated virus.
    Ou J; Tang Y; Xu J; Tucci J; Borys MC; Khetan A
    Biotechnol Bioeng; 2024 Jan; 121(1):53-70. PubMed ID: 37691172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pathways of recombinant adeno-associated virus production for gene therapy.
    Sha S; Maloney AJ; Katsikis G; Nguyen TNT; Neufeld C; Wolfrum J; Barone PW; Springs SL; Manalis SR; Sinskey AJ; Braatz RD
    Biotechnol Adv; 2021; 49():107764. PubMed ID: 33957276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward exascale production of recombinant adeno-associated virus for gene transfer applications.
    Cecchini S; Negrete A; Kotin RM
    Gene Ther; 2008 Jun; 15(11):823-30. PubMed ID: 18401433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms.
    Catalán-Tatjer D; Tzimou K; Nielsen LK; Lavado-García J
    Biotechnol Adv; 2024; 73():108370. PubMed ID: 38692443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical challenges and advances in recombinant adeno-associated virus (rAAV) biomanufacturing.
    Fu Q; Polanco A; Lee YS; Yoon S
    Biotechnol Bioeng; 2023 Sep; 120(9):2601-2621. PubMed ID: 37126355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart and Controllable rAAV Gene Delivery Carriers in Progenitor Cells for Human Musculoskeletal Regenerative Medicine with a Focus on the Articular Cartilage.
    Rey-Rico A; Cucchiarini M
    Curr Gene Ther; 2017; 17(2):127-138. PubMed ID: 28494738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology.
    Negrete A; Kotin RM
    Brief Funct Genomic Proteomic; 2008 Jul; 7(4):303-11. PubMed ID: 18632744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release strategies for rAAV-mediated gene delivery.
    Rey-Rico A; Cucchiarini M
    Acta Biomater; 2016 Jan; 29():1-10. PubMed ID: 26472612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy.
    Lipinski DM
    Adv Exp Med Biol; 2019; 1185():79-83. PubMed ID: 31884592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production.
    Zhang H; Xie J; Xie Q; Wilson JM; Gao G
    Hum Gene Ther; 2009 Sep; 20(9):922-9. PubMed ID: 19618999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal gene delivery by rAAV and DNA electroporation.
    Venkatesh A; Ma S; Langellotto F; Gao G; Punzo C
    Curr Protoc Microbiol; 2013; Chapter 14():Unit 14D.4. PubMed ID: 23408132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bound Protein- and Peptide-Based Strategies for Adeno-Associated Virus Vector-Mediated Gene Therapy: Where Do We Stand Now?
    Zhang X; Chai Z; Samulski RJ; Li C
    Hum Gene Ther; 2020 Nov; 31(21-22):1146-1154. PubMed ID: 32940063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.
    Rey-Rico A; Cucchiarini M
    Bioengineered; 2016 Apr; 7(3):175-88. PubMed ID: 27221233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging rAAV bioprocess understanding and next generation bioanalytics development.
    Escandell JM; Pais DA; Carvalho SB; Vincent K; Gomes-Alves P; Alves PM
    Curr Opin Biotechnol; 2022 Apr; 74():271-277. PubMed ID: 35007989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large-scale production of recombinant adeno-associated virus (rAAV)].
    Wang F; Diao Y; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1608-13. PubMed ID: 20222456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated viral vectors as gene delivery vehicles.
    Carter PJ; Samulski RJ
    Int J Mol Med; 2000 Jul; 6(1):17-27. PubMed ID: 10851261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
    Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.